180
Participants
Start Date
September 1, 2021
Primary Completion Date
March 1, 2022
Study Completion Date
May 25, 2022
Intranasal oxytocin
Each subject will be assigned to administration of oxytocin intranasal spray (24 IU).
Oral oxytocin
Each subject will be assigned to administration of oxytocin lingual spray (24 IU).
Placebo
An identical amount of intranasal administration of placebo (identical ingredients except the peptide - i.e. glycerine and sodium chloride) will be assigned to each subject.
University of Electronic Science and Technology of China(UESTC), Chengdu
University of Electronic Science and Technology of China
OTHER